Your browser doesn't support javascript.
loading
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma.
Takahashi, Shunji; Uemura, Motohide; Kimura, Tomokazu; Kawasaki, Yoshihide; Takamoto, Atsushi; Yamaguchi, Akito; Melhem-Bertrandt, Amal; Gartner, Elaina M; Inoue, Takashi; Akazawa, Rio; Kadokura, Takeshi; Tanikawa, Toshiki.
Afiliação
  • Takahashi S; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. s.takahashi-chemotherapy@jfcr.or.jp.
  • Uemura M; Osaka University Hospital, Osaka, Japan.
  • Kimura T; University of Tsukuba Hospital, Tsukuba, Japan.
  • Kawasaki Y; Tohoku University Hospital, Sendai, Japan.
  • Takamoto A; Okayama University Hospital, Okayama, Japan.
  • Yamaguchi A; Harasanshin Hospital, Fukuoka, Japan.
  • Melhem-Bertrandt A; Astellas Pharma Global Development, Northbrook, IL, USA.
  • Gartner EM; Seattle Genetics, Seattle, WA, USA.
  • Inoue T; Astellas Pharma, Inc., Tokyo, Japan.
  • Akazawa R; Astellas Pharma, Inc., Tokyo, Japan.
  • Kadokura T; Astellas Pharma, Inc., Tokyo, Japan.
  • Tanikawa T; Niigata Cancer Center Hospital, Niigata, Japan.
Invest New Drugs ; 38(4): 1056-1066, 2020 08.
Article em En | MEDLINE | ID: mdl-31444589

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article